Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia

A small molecule inhibitor of the Menin/Kmt2a interaction decreases

Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia

A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition

IJMS, Free Full-Text

Frontiers Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)—Gene Rearrangements

IJMS, Free Full-Text

PDF] Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo.

Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia

Role of the MOZ/MLL‐mediated transcriptional activation system for self‐renewal in normal hematopoiesis and leukemogenesis - Yokoyama - 2022 - The FEBS Journal - Wiley Online Library

Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia

A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1, Cancer Cell International